Search
Advertisement
reena mishra

Reena Mishra

Morepen labs reports yet another growth-filled quarter

by Reena Mishra |Feb 9, 2017

Company's topline goes up by 23 per cent, backed by a 74% jump in the sales of its bulk drug Montelukast in the Q3 of fiscal 2016-17.